Delaware
|
001-32616
|
98-0381367
|
(State
or other Jurisdiction of Identification Incorporation)
|
(Commission
File Number)
|
(IRS
Employer No.)
|
[
]
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
[
]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
[
]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
[
]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
BODISEN BIOTECH, INC. | ||
|
|
|
Date: November 17, 2006 | By: | /s/ Qiong Wang |
Qiong Wang |
||
Chief Executive Officer |